Exploring the FoxP3+ Lymphocytes and Their Correlation with VEGF in Canine Histiocytic Tumors
Δημοσιευμένα:
Μαΐ 16, 2025
Ενημερώθηκε:
2025-05-16
Εκδόσεις:
2025-05-16 (2)
Περίληψη
Histiocytic proliferative diseases in dogs include reactive diseases such as cutaneous histiocytosis and systemic histiocytosis and neoplastic diseases such as cutaneous histiocytoma, histiocytic sarcoma, and disseminated histiocytic sarcoma. The aim of our study was to investigate the intensity of VEGF staining with FoxP3-positive T lymphocytes in various histiocytic diseases in dogs. The study evaluated 23 cases diagnosed with histiocytic tumors. Immunostaining with Iba-1, E-cadherin, and CD3 antibodies was performed for differential diagnosis. Because of strong CD3 positivity, lymphoma was diagnosed in 2 cases. The diagnosis of histiocytic tumor was confirmed in 12 cases with intense Iba-1 positivity. In the other 9 cases, Iba-1-positive histiocytic cells were detected in the tumor tissue. Histopathologic examination of the 12 Iba-1-positive cases revealed that 4 cases were cutaneous histiocytomas, 3 cases were cutaneous histiocytosis, and 5 cases were histiocytic sarcomas (1 hemophagocytic histiocytic sarcoma). Mild E-cadherin positivity was detected in only one cutaneous histiocytoma and one histiocytic sarcoma. CD3- and FoxP3-positive T lymphocytes were counted and evaluated in 12 Iba-1-positive cases. In addition, VEGF staining revealed different degrees of positivity. Statistical analyzes revealed that there was a significant increase in CD3 positivity in histiocytic sarcoma and cutaneous histiocytosis cases compared with cutaneous histiocytoma cases in the group comparison. According to the correlation results of CD3, FoxP3, and VEGF levels, only a moderate negative correlation was found between FoxP3 and VEGF. According to the findings, increasing the amount of FoxP3-positive Tregs in canine histiocytic tumors may negatively correlate with VEGF-mediated angiogenesis.
Λεπτομέρειες άρθρου
- Πώς να δημιουργήσετε Αναφορές
-
Kaya, A., & Ipek, V. (2025). Exploring the FoxP3+ Lymphocytes and Their Correlation with VEGF in Canine Histiocytic Tumors. Περιοδικό της Ελληνικής Κτηνιατρικής Εταιρείας, 76(1), 8757–8766. https://doi.org/10.12681/jhvms.37565 (Original work published 19 Απρίλιος 2025)
- Τεύχος
- Τόμ. 76 Αρ. 1 (2025)
- Ενότητα
- Research Articles
Αυτή η εργασία είναι αδειοδοτημένη υπό το CC Αναφορά Δημιουργού – Μη Εμπορική Χρήση 4.0.
Οι συγγραφείς των άρθρων που δημοσιεύονται στο περιοδικό διατηρούν τα δικαιώματα πνευματικής ιδιοκτησίας επί των άρθρων τους, δίνοντας στο περιοδικό το δικαίωμα της πρώτης δημοσίευσης.
Άρθρα που δημοσιεύονται στο περιοδικό διατίθενται με άδεια Creative Commons 4.0 Non Commercial και σύμφωνα με την άδεια μπορούν να χρησιμοποιούνται ελεύθερα, με αναφορά στο/στη συγγραφέα και στην πρώτη δημοσίευση για μη κερδοσκοπικούς σκοπούς.
Οι συγγραφείς μπορούν να καταθέσουν το άρθρο σε ιδρυματικό ή άλλο αποθετήριο ή/και να το δημοσιεύσουν σε άλλη έκδοση, με υποχρεωτική την αναφορά πρώτης δημοσίευσης στο J Hellenic Vet Med Soc
Οι συγγραφείς ενθαρρύνονται να καταθέσουν σε αποθετήριο ή να δημοσιεύσουν την εργασία τους στο διαδίκτυο πριν ή κατά τη διαδικασία υποβολής και αξιολόγησής της.
Λήψεις
Τα δεδομένα λήψης δεν είναι ακόμη διαθέσιμα.
Αναφορές
Abrams VK, Hwang B, Lesnikova M, Gass MJ, Wayner E, Castilla-
Llorente C, Georges GE, Nash RA (2010) A Novel Monoclonal
Antibody Specific for Canine CD25 (P4A10): Selection and Evaluation
of Canine Tregs. Vet. Immunol. Immunopathol. 135:257.
Affolter VK, Moore PF (2002) Localized and Disseminated Histiocytic
Sarcoma of Dendritic Cell Origin in Dogs. Vet. Pathol. 39:74-83.
Azakami D, Bonkobara M, Washizu T, Iida A, Kondo M, Kato R, Niikura
Y, Iwaki S, Tamahara S, Matsuki N, Ono K (2006) Establishment and
biological characterization of canine histiocytic sarcoma cell lines. J.
Vet. Med. Sci. 68:1343-6.
Bates GJ, Fox SB, Han C, Leek RD, Garcia JF, Harris AL, Banham AH
(2006) Quantification of regulatory T cells enables the identification
of high-risk breast cancer patients and those at risk of late relapse. J.
Clin. Oncol. 24:5373-5380.
Belluco S, Sammarco A, Sapin P, Lurier T, Marchal T (2020) FOXP3,
CD208, and CD206 Expression in Canine Cutaneous Histiocytoma:
https://doi.org/10.1177/0300985820941818 57:599-607.
Berk E, Muthuswamy R (2011) Treg-mediated angiogenesis and tolerance
is programmed by hypoxia in the tumor microenvironment. Immunotherapy
:1429.
Beyer M, Schultze JL (2006) Regulatory T cells in cancer. Blood 108:804-
Biller BJ, Elmslie RE, Burnett RC, Avery AC, Dow SW (2007) Use of
FoxP3 expression to identify regulatory T cells in healthy dogs and
dogs with cancer. Vet. Immunol. Immunopathol. 116:69-78.
Biller BJ, Guth A, Burton JH, Dow SW (2010) Decreased Ratio of CD8+
T Cells to Regulatory T Cells Associated with Decreased Survival in
Dogs with Osteosarcoma. J. Vet. Intern. Med. 24:1118.
De Brot S, Ntekim A, Cardenas R, James V, Allegrucci C, Heery DM,
Bates DO, Ødum N, Persson JL, Mongan NP (2015) Regulation of
vascular endothelial growth factor in prostate cancer. Endocr. Relat.
Cancer 22:R107-R123.
Brunkow ME, Jeffery EW, Hjerrild KA, Paeper B, Clark LB, Yasayko SA,
Wilkinson JE, Galas D, Ziegler SF, Ramsdell F (2001) Disruption
of a new forkhead/winged-helix protein, scurfin, results in the fatal
lymphoproliferative disorder of the scurfy mouse. Nat. Genet. 2001
27:68-73.
Bulliard Y, Jolicoeur R, Zhang J, Dranoff G, Wilson NS, Brogdon JL
(2014) OX40 engagement depletes intratumoral Tregs via activating
FcγRs, leading to antitumor efficacy. Immunol. Cell Biol. 92:475-
Campbell DJ, Koch MA (2011) Phenotypical and functional specialization
of FOXP3+ regulatory T cells. Nat. Rev. Immunol. 11:119-130.
Carreras J, Lopez-Guillermo A, Fox BC, Colomo L, Martinez A, Roncador
G, Montserrat E, Campo E, Banham AH (2006) High numbers
of tumor-infiltrating FOXP3-positive regulatory T cells are associated
with improved overall survival in follicular lymphoma. Blood
:2957-2964.
Carvalho MI, Pires I, Prada J, Gregório H, Lobo L, Queiroga FL (2016)
Intratumoral FoxP3 expression is associated with angiogenesis and
prognosis in malignant canine mammary tumors. Vet. Immunol. Immunopathol.
:1-9.
Carvalho MI, Pires I, Prada J, Queiroga FL (2014) A role for T-lymphocytes
in human breast cancer and in canine mammary tumors.
Biomed Res. Int. 2014.
Casares N, Arribillaga L, Sarobe P, Dotor J, Lopez-Diaz de Cerio A, Melero
I, Prieto J, Borrás-Cuesta F, Lasarte JJ (2003) CD4+/CD25+ regulatory
cells inhibit activation of tumor-primed CD4+ T cells with
IFN-gamma-dependent antiangiogenic activity, as well as long-lasting
tumor immunity elicited by peptide vaccination. J. Immunol.
:5931-5939.
Curiel TJ (2007) Tregs and rethinking cancer immunotherapy. J. Clin. In vest. 117:1167.
Curti BD, Kovacsovics-Bankowski M, Morris N, Walker E, Chisholm L,
Floyd K, Walker J, Gonzalez I, Meeuwsen T, Fox BA, Moudgil T,
Miller W, Haley D, Coffey T, Fisher B, Delanty-Miller L, Rymarchyk
N, Kelly T, Crocenzi T, Bernstein E, Sanborn R, Urba WJ, Weinberg
AD (2013) OX40 is a potent immune stimulating target in late stage
cancer patients. Cancer Res. 73:7189.
Elkord E, Alcantar-Orozco EM, Dovedi SJ, Tran DQ, Hawkins RE, Gilham
DE (2010) T regulatory cells in cancer: recent advances and therapeutic
potential. Expert Opin. Biol. Ther. 10:1573-1586.
Facciabene A, Peng X, Hagemann IS, Balint K, Barchetti A, Wang LP,
Gimotty PA, Gilks CB, Lal P, Zhang L, Coukos G (2011) Tumour
hypoxia promotes tolerance and angiogenesis via CCL28 and T(reg)
cells. Nature 475:226-230.
Fontenot JD, Gavin MA, Rudensky AY (2003) Foxp3 programs the development
and function of CD4+CD25+ regulatory T cells. Nat. Immunol.
:986-992.
Garden OA, Pinheiro D, Cunningham F (2011) All creatures great and
small: regulatory T cells in mice, humans, dogs and other domestic
animal species. Int. Immunopharmacol. 11:576-588.
Giatromanolaki A, Bates GJ, Koukourakis MI, Sivridis E, Gatter KC,
Harris AL, Banham AH (2008) The presence of tumor-infiltrating
FOXP3+ lymphocytes correlates with intratumoral angiogenesis in
endometrial cancer. Gynecol. Oncol. 110:216-221.
Grabenbauer GG, Lahmer G, Distel L, Niedobitek G (2006) Tumor-infiltrating
cytotoxic T cells but not regulatory T cells predict outcome
in anal squamous cell carcinoma. Clin. Cancer Res. 12:3355-3360.
Gross T, Ihrke P, Walder E, Affolter V (2005) Histiocytic tumors. In: . Ski.
Dis. dog cat 2nd editio. Blackwell Science Ltd, pp. 848-851.
Hatziioannou A, Alissafi T, Verginis P (2017) Myeloid-derived suppressor
cells and T regulatory cells in tumors: unraveling the dark side of the
force. J. Leukoc. Biol. 102:407-421.
Hinkle D, Wiersma W, Jurs S (2003) Applied Statistics for the Behavioral
Sciences 5th ed. Boston: Houghton Mifflin.
Hirako A, Sugiyama A, Sakurai M, Ozaki K, Sakai H, Takeuchi T, Morita
T, Moore PF (2015) Cutaneous histiocytic sarcoma with E-cadherin
expression in a Pembroke Welsh Corgi dog. J. Vet. Diagn. Invest.
:589-595.
Ipek V, Cangul IT, Akkoc A (2021) Comparative Evaluation of the Cytological,
Histopathological and Immunohistochemical Findings of Canine
Cutaneous and Subcutaneous Masses. Acta Vet. Brno. 71:61-84.
Janeway C, Travers P, Walport M (1999) Infection and innate immunity.
In: Janeway, C, Travers, P, editors. Immune Syst. Heal. Dis. New
York: Garland Publ, pp. 363-374.
Kim JH, Chon SK, Im KS, Kim NH, Cho KW, Sur JH (2013) Infiltrating
Foxp3+ regulatory T cells and histopathological features in canine
classical and spermatocytic seminomas. Reprod. Domest. Anim.
:218-222.
Kim JH, Hur JH, Lee SM, Im KS, Kim NH, Sur JH (2012) Correlation
of Foxp3 positive regulatory T cells with prognostic factors in canine
mammary carcinomas. Vet. J. 193:222-227.
Köhler C (2007) Allograft inflammatory factor-1/Ionized calcium-binding
adapter molecule 1 is specifically expressed by most subpopulations
of macrophages and spermatids in testis. Cell Tissue Res. 330:291-
Lan RY, Mackay IR, Eric Gershwin M (2007) Regulatory T cells in the
prevention of mucosal inflammatory diseases: Patrolling the border.
J. Autoimmun. 29:272.
Li X, Gao Y, Li J, Zhang K, Han J, Li W, Hao Q, Zhang W, Wang S,
Zeng C, Zhang W, Zhang Y, Li M, Zhang C (2018) FOXP3 inhibits
angiogenesis by downregulating VEGF in breast cancer. Cell Death
Dis. 2018 97 9:1-12.
Liu S, Liu D, Li J, Zhang D, Chen Q (2016) Regulatory T cells in oral
squamous cell carcinoma. J. Oral Pathol. Med. 45:635-639.
Luna LG (1968) Manual of Histologic Staining Methods of the Armed
Forces Institute of Pathology. 3rd Edition, McGraw-Hill, New York
Lužnik Z, Anchouche S, Dana R, Yin J (2020) Regulatory T Cells in Angiogenesis.
J. Immunol. 205:2557-2565.
Maae E, Nielsen M, Steffensen KD, Jakobsen EH, Jakobsen A, Sørensen
FB (2011) Estimation of immunohistochemical expression of VEGF
in ductal carcinomas of the breast. J. Histochem. Cytochem. 59(8):
-760.
Maeda S, Ohno K, Fujiwara-Igarashi A, Uchida K, Tsujimoto H (2016)
Changes in Foxp3-Positive Regulatory T Cell Number in the Intestine
of Dogs With Idiopathic Inflammatory Bowel Disease and Intestinal
Lymphoma. Vet. Pathol. 53:102-112.
Marcinowska A, Constantino-Casas F, Williams T, Hoather T, Blacklaws
B, Dobson J (2017) T Lymphocytes in Histiocytic Sarcomas of
Flat-Coated Retriever Dogs. Vet. Pathol. 54:605-610.
Miller AM, Lundberg K, Özenci V, Banham AH, Hellström M, Egevad L,
Pisa P (2006) CD4+CD25high T cells are enriched in the tumor and
peripheral blood of prostate cancer patients. J. Immunol. 177:7398-
Moes N, Rieuxlaucat F, Begue B, Verdier J, Neven B, Patey N, Torgerson
TT, Picard C, Stolzenberg M, Ruemmele C, Rings EH, Casanova
J, Piloquet H, Biver A, Breton A, Ochs HD, Hermine O, Fischer
A, Goulet O, Cerfbensussan N, Ruemmele FM (2010) Reduced expression
of FOXP3 and regulatory T-cell function in severe forms of
early-onset autoimmune enteropathy. Gastroenterology 139:770-778.
Moore PF (2014) A Review of Histiocytic Diseases of Dogs and Cats. Vet.
Pathol. 51:167-184.
Moore PF, Schrenzel MD, Affolter VK, Olivry T, Naydan D (1996) Canine
cutaneous histiocytoma is an epidermotropic Langerhans cell
histiocytosis that expresses CD1 and specific beta 2-integrin molecules.
Am. J. Pathol. 148:1699-708.
Moore P (2004) The histiocytic disease complex. In: . Proc Annu Meet
Coll Vet Intern Med. Minneapolis, Minnesota, pp. 437-438.
Moore P (2017) Canine and Feline Histiocytic Diseases. In: Meuten, D,
editor. Tumors Domest. Anim. 5th ed. Iowa: Wiley Blackwell, pp.
-336.
Muir CF, Priestnall SL, Hibbert A, Brown C, Garden OA, Scase T (2017)
Prevalence of FoxP3+ Cells Does Not Correlate With Ki67 Expression
in Canine Diffuse Large B-cell Lymphoma. J. Comp. Pathol.
:15-22.
Mukaka M (2012) A guide to appropriate use of correlation coefficient in
medical research. Malawi Med. J. 24:69-71.
Nishikawa H, Sakaguchi S (2014) Regulatory T cells in cancer immunotherapy.
Curr. Opin. Immunol. 27:1-7.
O’Neill K, Guth A, Biller B, Elmslie R, Dow S (2009) Changes in regulatory
T cells in dogs with cancer and associations with tumor type. J.
Vet. Intern. Med. 23:875-881.
Oh SY, Ryu HH, Yoo DY, Hwang IK, Kweon OK, Kim WH (2014) Evaluation
of FOXP3 expression in canine mammary gland tumours. Vet.
Comp. Oncol. 12:20-28.
Paździor-Czapula K, Rotkiewicz T, Otrocka-Domagała I, Gesek M,
Śmiech A (2015) Morphology and immunophenotype of canine cutaneous
histiocytic tumours with particular emphasis on diagnostic
application. Vet. Res. Commun. 39:7.
Pierezan F, Mansell J, Ambrus A, Hoffmann AR (2014) Immunohistochemical
expression of ionized calcium binding adapter molecule 1
in cutaneous histiocytic proliferative, neoplastic and inflammatory
disorders of dogs and cats. J. Comp. Pathol. 151:347-351.
Piersma SJ, Welters MJP, van der Burg SH (2008) Tumor-specific regulatory
T cells in cancer patients. Hum. Immunol. 69:241-249.
Potente M, Gerhardt H, Carmeliet P (2011) Basic and therapeutic aspects
of angiogenesis. Cell 146:873-887.
R.Walker M, Kasprowicz DJ, Gersuk VH, Bènard A, Landeghen M Van,
Buckner JH, Ziegler SF (2003) Induction of FoxP3 and acquisition
of T regulatory activity by stimulated human CD4+CD25- T cells. J.
Clin. Invest. 112:1437.
Ramos-Vara JA, Miller MA (2011) Immunohistochemical Expression of
E-cadherin Does Not Distinguish Canine Cutaneous Histiocytoma
From Other Canine Round Cell Tumors. Vet. Pathol. 48:758-763.
Sakaguchi S, Sakaguchi N, Asano M, Itoh M, Toda M (1995) Immunologic
self-tolerance maintained by activated T cells expressing IL-2
receptor alpha-chains (CD25). Breakdown of a single mechanism
of self-tolerance causes various autoimmune diseases. J. Immunol.
:1151-1164.
Sakaguchi S, Yamaguchi T, Nomura T, Ono M (2008) Regulatory T cells
and immune tolerance. Cell 133:775-787.
Sakai K, Maeda S, Yamada Y, Chambers JK, Uchida K, Nakayama H, Yonezawa
T, Matsuki N (2018) Association of tumour-infiltrating regu latory T cells with adverse outcomes in dogs with malignant tumours.
Vet. Comp. Oncol. 16:330-336.
Schulze JO, Quedenau C, Roske Y, Adam T, Schüler H, Behlke J, Turnbull
AP, Sievert V, Scheich C, Mueller U, Heinemann U, Büssow K
(2008) Structural and functional characterization of human Iba proteins.
FEBS J. 275:4627-4640.
Shortman K, Liu YJ (2002) Mouse and human dendritic cell subtypes.
Nat. Rev. Immunol. 2002 23 2:151-161.
Terme M, Colussi O, Marcheteau E, Tanchot C, Tartour E, Taieb J (2012)
Modulation of immunity by antiangiogenic molecules in cancer. Clin.
Dev. Immunol. 2012.
Tominaga M, Horiuchi Y, Ichikawa M, Yamashita M, Okano K, Jikumaru
Y, Nariai Y, Kadosawa T (2010) Flow cytometric analysis of peripheral
blood and tumor-infiltrating regulatory T cells in dogs with oral
malignant melanoma. J. Vet. Diagn. Invest. 22:438-441.
Wang W, Hodkinson P, McLaren F, MacKinnon A, Wallace W, Howie
S, Sethi T (2012) Small cell lung cancer tumour cells induce regulatory
T lymphocytes, and patient survival correlates negatively with
FOXP3+ cells in tumour infiltrate. Int. J. cancer 131.
Whiteside TL (2014) Induced regulatory T cells in inhibitory microenvironments
created by cancer. Expert Opin. Biol. Ther. 14:1411-1425.
Wolf A, Wolf D, Steurer M, Gastl G, Gunsilius E, Grubeck-Loebenstein
B (2003) Increase of Regulatory T Cells in the Peripheral Blood of
Cancer Patients1 | Clinical Cancer Research | American Association
for Cancer Research. Clin. Cancer Res. 9:606-612.
Yan M, Jene N, Byrne D, Millar EKA, O’Toole SA, McNeil CM, Bates
GJ, Harris AL, Banham AH, Sutherland RL, Fox SB (2011) Recruitment
of regulatory T cells is correlated with hypoxia-induced CXCR4
expression, and is associated with poor prognosis in basal-like breast
cancers. Breast Cancer Res. 13.
Yu JL, Rak JW (2003) Inflammatory and immune cells in tumour angiogenesis
and arteriogenesis. Breast Cancer Res. 5:83-88.
Zhan H-L, Gao X, Zhou X-F, Pu X-Y, Wang D-J (2012) Presence of Tumour-
infiltrating FOXP3+ Lymphocytes Correlates with Immature
Tumour Angiogenesis in Renal Cell Carcinomas. Asian Pacific J.
Cancer Prev. 13:867-872
